[go: up one dir, main page]

AU2002252773A1 - Retina-specific human proteins c70rf9, c120rf7, mpp4 and f379 - Google Patents

Retina-specific human proteins c70rf9, c120rf7, mpp4 and f379

Info

Publication number
AU2002252773A1
AU2002252773A1 AU2002252773A AU5277302A AU2002252773A1 AU 2002252773 A1 AU2002252773 A1 AU 2002252773A1 AU 2002252773 A AU2002252773 A AU 2002252773A AU 5277302 A AU5277302 A AU 5277302A AU 2002252773 A1 AU2002252773 A1 AU 2002252773A1
Authority
AU
Australia
Prior art keywords
c70rf9
c120rf7
mpp4
retina
human proteins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002252773A
Inventor
Heidi Barbara Stohr
Bernhard Heinrich Freidrich Weber
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lynkeus Boitech GmbH
Original Assignee
MultiGene Biotech GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MultiGene Biotech GmbH filed Critical MultiGene Biotech GmbH
Publication of AU2002252773A1 publication Critical patent/AU2002252773A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Ophthalmology & Optometry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU2002252773A 2000-11-29 2001-11-29 Retina-specific human proteins c70rf9, c120rf7, mpp4 and f379 Abandoned AU2002252773A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US25375100P 2000-11-29 2000-11-29
US60/253,751 2000-11-29
PCT/EP2001/013940 WO2002044366A2 (en) 2000-11-29 2001-11-29 Retina-specific human proteins c70rf9, c120rf7, mpp4 and f379

Publications (1)

Publication Number Publication Date
AU2002252773A1 true AU2002252773A1 (en) 2002-06-11

Family

ID=22961555

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002252773A Abandoned AU2002252773A1 (en) 2000-11-29 2001-11-29 Retina-specific human proteins c70rf9, c120rf7, mpp4 and f379

Country Status (6)

Country Link
US (1) US20030054446A1 (en)
EP (1) EP1337640A2 (en)
JP (1) JP2004514445A (en)
AU (1) AU2002252773A1 (en)
CA (1) CA2430082A1 (en)
WO (1) WO2002044366A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2401946A1 (en) * 2000-03-06 2001-09-13 Takeda Chemical Industries, Ltd. Rfrp-containing prolactin secretion regulatory agent
US7309487B2 (en) * 2004-02-09 2007-12-18 George Inana Methods and compositions for detecting and treating retinal diseases
WO2005095604A1 (en) * 2004-04-02 2005-10-13 Takeda Pharmaceutical Company Limited Rf rp transgenic animal
WO2010070394A1 (en) * 2008-12-17 2010-06-24 Universite Pierre Et Marie Curie-Paris Vi Modulators of the cx3cr1 receptor and therapeutic uses thereof
CN111690729A (en) * 2019-03-12 2020-09-22 上海市第一人民医院 Method for diagnosing wet age-related macular degeneration by measuring NPVF protein in peripheral blood

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL154598B (en) * 1970-11-10 1977-09-15 Organon Nv PROCEDURE FOR DETERMINING AND DETERMINING LOW MOLECULAR COMPOUNDS AND PROTEINS THAT CAN SPECIFICALLY BIND THESE COMPOUNDS AND TEST PACKAGING.
US3817837A (en) * 1971-05-14 1974-06-18 Syva Corp Enzyme amplification assay
US3939350A (en) * 1974-04-29 1976-02-17 Board Of Trustees Of The Leland Stanford Junior University Fluorescent immunoassay employing total reflection for activation
US3996345A (en) * 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
US4227437A (en) * 1977-10-11 1980-10-14 Inloes Thomas L Frequency detecting apparatus
US4275149A (en) * 1978-11-24 1981-06-23 Syva Company Macromolecular environment control in specific receptor assays
US4366241A (en) * 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
US4816567A (en) * 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
DE69833189T2 (en) * 1997-02-27 2006-08-03 Baylor College Of Medicine, Houston NUCLEIC ACID SEQUENCES FOR ATP-BINDING CASSETTE TRANSPORTERS
WO1999025721A1 (en) * 1997-11-13 1999-05-27 The Hospital For Sick Children Detection and treatment of retinal degenerative disease
CN1333786A (en) * 1998-11-13 2002-01-30 武田药品工业株式会社 Novel G protein-coupled receptor protein, its DNA

Also Published As

Publication number Publication date
US20030054446A1 (en) 2003-03-20
JP2004514445A (en) 2004-05-20
CA2430082A1 (en) 2002-06-06
EP1337640A2 (en) 2003-08-27
WO2002044366A2 (en) 2002-06-06
WO2002044366A3 (en) 2003-01-03

Similar Documents

Publication Publication Date Title
ZA200407868B (en) 17alpha-Alkyl-17beta-oxy-estratrienes, uses thereof and pharmaceutical preparations.
AU2001271744A1 (en) Leucine-rich repeat proteins, zlrr7, zlrr8 and zlrr9
AU2002340999A1 (en) Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use
AU2002235128A1 (en) Expression miniarrays and uses thereof
HK1061679A1 (en) Phenylsulfonyl-1,3-dihydro-2h-indole-2-ibe derivatives, their preparation and their therapeutic use.
AU2002359126A1 (en) Benzodiazepine derivatives, preparation thereof and use thereof
AU2002359123A1 (en) Benzodiazepine derivatives, preparation thereof and use thereof
AU2002224553A1 (en) Human proteases
AU7748200A (en) Hypoxia-related human genes, proteins, and uses thereof
AU2001286721A1 (en) Human interleukin-four induced protein
AU2001282037A1 (en) Proton-translocating retinal protein
AU2002227925A1 (en) Human beta-defensin-3
AU2001232244A1 (en) Drug comprising combination
AU2002252773A1 (en) Retina-specific human proteins c70rf9, c120rf7, mpp4 and f379
AU2001284084A1 (en) Polyfluoroalkyltriazole derivatives, preparation and therapeutic use thereof
AU2002229870A1 (en) Mikanolide derivatives, their preparation and therapeutic uses
MXPA03006162A (en) Mikanolide derivatives, their preparation and therapeutic uses.
AU2001282521A1 (en) OCT preparations
AU2002320079A1 (en) Vaccines, immunotherapeutics and methods of using the same
GB0217548D0 (en) Four human zinc-finger-containing proteins:MDZ3.MDZ4,MDZ7 and MDZ12
AU2001244863A1 (en) Apoptin-associating protein
AU2001237518A1 (en) Polyfluoroalkylimidazole derivatives, their preparation and therapeutic application
IL161859A0 (en) 3-Heteroaryl-3.5-dihydro-4-oxo-4H-pyridazinoÄ4.5-BÜindole-1-carboxamide derivatives, their preparation and therapeutic use
AU2001255380A1 (en) Human interferon, zinf2
AU2001288231A1 (en) Human secreted protein, zzp1